Prospective Cohort Study of Protected Children
ESPER
PEGASE3, Experimental Program of a Standardized Health Protocol Applied to Children Who Benefited From a Child Protection Measure Before the Age of Five: Effectiveness and Efficiency
3 other identifiers
observational
220
1 country
7
Brief Summary
A significant number of children are abused or neglected every year. This exposure is associated with short- and long-term consequences for their mental and somatic health. In France, 308,000 minors are benefiting from at least one child protective service or measure. There are few data on the health status of this population, and how it is evolving. Against this backdrop, interventions are needed to address the many needs of these children early and comprehensively, both in the short and long term. The PEGASE program, funded by the French government under Article 51, aims to ensure adequate medical follow-up - both somatic and psychiatric - for children taken into care by child protective services (CPS). An evaluation of the program's effectiveness and efficiency is needed to inform public decision-making on the appropriateness of extending it to all children under CPS's care. This requires the creation of a control cohort of children followed by CPS but not benefiting from the PEGASE program, the ESPER cohort (Prospective cohort study of protected children), which will enable us to carry out a comparative evaluation of the PEGASE program, as well as to provide information on the health of children followed by the CPS at the time of their placement and its evolution over time, data which are rare in France. The main objective is to evaluate the effectiveness of the PEGASE program on the evolution of the mental health of children followed by the CPS after 2 years of follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2025
Longer than P75 for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2025
CompletedFirst Posted
Study publicly available on registry
February 3, 2025
CompletedStudy Start
First participant enrolled
February 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 17, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 17, 2029
April 13, 2026
April 1, 2026
4 years
January 17, 2025
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mental health
The primary endpoint is the ASQ-SE questionnaire score after two years of follow-up, dichotomized into: 1/ Failure: the child is above the alert threshold defined for his/her age, indicating the need to initiate or maintain adapted care; 2/ Success: the child is below the age-defined alert threshold (i.e. "within the norm" for his or her age). The ASQ-SE assesses socio-emotional development, a reflection of mental health in young children. The higher the score, the more worrying the child's condition. As socio-emotional development evolves with age, nine questionnaires are available, depending on the child's age: 2, 6, 12, 18, 24, 30, 36, 48 and 60 months. The questionnaire is made up of around 36 items (the number of items varies according to the age of the child) and is associated with a score (the total score is a function of the number of items, and therefore differs according to age) and alert thresholds.
two years of follow-up
Secondary Outcomes (12)
Mental health_ASQ-SE questionnaire
1 and 2 years of follow-up
Body mass index
1 and 2 years of follow-up
Growth restriction
1 and 2 years of follow-up
Communication skills
1 and 2 years of follow-up
Gross motor development
1 and 2 years of follow-up
- +7 more secondary outcomes
Other Outcomes (5)
ASQ-3
at inclusion, 1 year and 2 years of follow-up
BMI
at inclusion, 1 year and 2 years of follow-up
Growth restriction
at inclusion, 1 year and 2 years of follow-up
- +2 more other outcomes
Study Arms (1)
ESPER
Children under the care of child protective services and followed using usual practices
Interventions
Eligibility Criteria
Children from the control cohort will be included in the participating services of 7 French departments (the territorial level responsible for CPS in France) not participating in the PEGASE program. The child protection measure can be exercised either in an institution, a foster family or an open environment service.
You may qualify if:
- Child under the supervision of child protective services,
- Arriving for the first time in a participating center,
- Less than 42 months old (i.e. 3 and a half years),
- Non-opposition of the holders of parental authority (in the event of impossibility to obtain the non-opposition of both holders of parental authority, the non-opposition of one of them will be obtained).
You may not qualify if:
- Children whose child protection measure has not been confirmed by a judicial or administrative decision.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assistance Publique - Hôpitaux de Parislead
- Saint-Exupéry Associationcollaborator
Study Sites (7)
Maternal and Child Protection - The Eure Department
Évreux, France, 27000, France
Departmental institution to support - accompany - educate
Lille, France, 59000, France
Moselle Departmental Children's Centre
Metz, France, 57050, France
Maternal and Child Protection
Rouen, France, 76100, France
Maternal and Child Protection
Saint-Brieuc, France, 22000, France
Children and Family Home of the Loire
Saint-Genest-Lerpt, France, 42530, France
Departmental Observatory for Child Protection
Toulon, France, 83000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Morgane MICHEL, MD
Clinical Epidemiology Unit, Robert Debré Hospital (Assistance Publique - Hôpitaux de Paris)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2025
First Posted
February 3, 2025
Study Start
February 18, 2025
Primary Completion (Estimated)
February 17, 2029
Study Completion (Estimated)
February 17, 2029
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share